PL1713446T3 - Nielamelarne trójskładnikowe kompozycje lipidów - Google Patents

Nielamelarne trójskładnikowe kompozycje lipidów

Info

Publication number
PL1713446T3
PL1713446T3 PL05701965T PL05701965T PL1713446T3 PL 1713446 T3 PL1713446 T3 PL 1713446T3 PL 05701965 T PL05701965 T PL 05701965T PL 05701965 T PL05701965 T PL 05701965T PL 1713446 T3 PL1713446 T3 PL 1713446T3
Authority
PL
Poland
Prior art keywords
compositions
amphiphile
lipid compositions
component
lamellar lipid
Prior art date
Application number
PL05701965T
Other languages
English (en)
Polish (pl)
Inventor
Markus Johnsson
Fredrik Tiberg
Original Assignee
Camurus Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0401515.2A external-priority patent/GB0401515D0/en
Priority claimed from GB0407936A external-priority patent/GB0407936D0/en
Application filed by Camurus Ab filed Critical Camurus Ab
Publication of PL1713446T3 publication Critical patent/PL1713446T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL05701965T 2004-01-23 2005-01-21 Nielamelarne trójskładnikowe kompozycje lipidów PL1713446T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0401515.2A GB0401515D0 (en) 2004-01-23 2004-01-23 Compositions
GB0407936A GB0407936D0 (en) 2004-04-07 2004-04-07 Compositions
PCT/GB2005/000202 WO2005070394A2 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions
EP05701965A EP1713446B1 (en) 2004-01-23 2005-01-21 Ternary non-lamellar lipid compositions

Publications (1)

Publication Number Publication Date
PL1713446T3 true PL1713446T3 (pl) 2011-05-31

Family

ID=34809883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05701965T PL1713446T3 (pl) 2004-01-23 2005-01-21 Nielamelarne trójskładnikowe kompozycje lipidów

Country Status (8)

Country Link
US (1) US8182834B2 (enExample)
EP (1) EP1713446B1 (enExample)
JP (1) JP4966018B2 (enExample)
AT (1) ATE489942T1 (enExample)
CA (1) CA2554052C (enExample)
DE (1) DE602005025083D1 (enExample)
PL (1) PL1713446T3 (enExample)
WO (1) WO2005070394A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0401513D0 (en) * 2004-01-23 2004-02-25 Camurus Ab Compositions
ATE501710T1 (de) 2005-01-14 2011-04-15 Camurus Ab Somatostatin-analog-formulierungen
EP1848403B8 (en) * 2005-01-14 2010-05-19 Camurus Ab Topical bioadhesive formulations
ATE462409T1 (de) 2005-01-14 2010-04-15 Camurus Ab Topische bioadhäsive formulierungen
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
JP5171262B2 (ja) * 2005-01-14 2013-03-27 カムルス エービー ソマトスタチン類似体製剤
CA2595385C (en) 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
CA2609810C (en) 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
CN103315954A (zh) 2005-07-18 2013-09-25 麻萨诸塞州洛厄尔大学 制备与使用纳米乳剂的组合物和方法
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2008070538A2 (en) 2006-12-01 2008-06-12 Anterios, Inc. Micellar nanoparticles comprising botulinum toxin
CN107080703A (zh) 2006-12-01 2017-08-22 安特里奥公司 肽纳米粒子和其用途
CA2688415C (en) 2007-05-31 2015-11-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
RS52337B (sr) * 2007-06-19 2012-12-31 Neubourg Skin Care Gmbh & Co. Kg Dms kreme na bazi pene
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
PT104158B (pt) * 2008-08-18 2011-02-24 Univ Do Minho Aplicação da monooleína como novo lípido adjuvante em lipofecção
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
CN104093399B (zh) 2011-12-05 2018-03-13 卡穆鲁斯公司 鲁棒性控释肽制剂
IN2014DN09831A (enExample) 2012-05-25 2015-08-07 Camurus Ab
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
CN113905982A (zh) 2019-03-15 2022-01-07 沙特阿拉伯石油公司 Janus纳米材料的批量合成
WO2021011755A1 (en) 2019-07-16 2021-01-21 Saudi Arabian Oil Company Multipurpose microfluidics devices for rapid on-site optical chemical analysis
US11422285B2 (en) 2020-06-17 2022-08-23 Saudi Arabian Oil Company Nanofluidic chips as micromodels for carbonate reservoirs
US11827850B2 (en) 2020-07-24 2023-11-28 Saudi Arabian Oil Company Enhanced oil recovery with janus nanoparticles
US11773715B2 (en) 2020-09-03 2023-10-03 Saudi Arabian Oil Company Injecting multiple tracer tag fluids into a wellbore
US11660595B2 (en) 2021-01-04 2023-05-30 Saudi Arabian Oil Company Microfluidic chip with multiple porosity regions for reservoir modeling
US11534759B2 (en) 2021-01-22 2022-12-27 Saudi Arabian Oil Company Microfluidic chip with mixed porosities for reservoir modeling
US12253467B2 (en) 2021-12-13 2025-03-18 Saudi Arabian Oil Company Determining partition coefficients of tracer analytes
US12000278B2 (en) 2021-12-16 2024-06-04 Saudi Arabian Oil Company Determining oil and water production rates in multiple production zones from a single production well
US12352146B2 (en) 2023-09-11 2025-07-08 Saudi Arabian Oil Company Method for well stimulation using nanobubbles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI941538L (fi) 1991-10-04 1994-05-31 Gs Biochem Ab Partikkelit, menetelmä niiden valmistamiseksi ja niiden käyttö
SE518578C2 (sv) 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
TR199901008T1 (xx) 1997-09-09 2000-02-21 Select Release, L.C. Kaplanm�� partik�ller, yap�m� ve kullan�m y�ntemleri.
ATE283034T1 (de) * 1998-04-27 2004-12-15 Opperbas Holding Bv Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen
US6537575B1 (en) * 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US7008646B2 (en) 2001-02-20 2006-03-07 Patrick Thomas Spicer Cubic liquid crystalline compositions and methods for their preparation
US6936187B2 (en) 2001-02-21 2005-08-30 Matthew Lawrence Lynch Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
US6656385B2 (en) 2001-02-21 2003-12-02 The Procter & Gamble Company Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
DE602004017198D1 (de) 2003-08-04 2008-11-27 Camurus Ab Verfahren zum beladen von amphiphilen teilchen mit wirkstoffen
GB0322033D0 (en) 2003-09-19 2003-10-22 Camurus Ab Composition

Also Published As

Publication number Publication date
WO2005070394A2 (en) 2005-08-04
JP4966018B2 (ja) 2012-07-04
CA2554052C (en) 2013-10-22
DE602005025083D1 (enExample) 2011-01-13
US20080206317A1 (en) 2008-08-28
JP2007518784A (ja) 2007-07-12
US8182834B2 (en) 2012-05-22
ATE489942T1 (de) 2010-12-15
EP1713446B1 (en) 2010-12-01
WO2005070394A3 (en) 2006-01-26
EP1713446A2 (en) 2006-10-25
CA2554052A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
PL1713446T3 (pl) Nielamelarne trójskładnikowe kompozycje lipidów
WO2007027941A3 (en) Compositions and methods for preparation of poorly water soluble drugs with increased stability
MX2007003162A (es) Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa.
NO20062798L (no) Anvendelse av en vannholdig dispersjon av i det minste en bio-nedbrytbar polymer inneholdende i det minste et stabiliseringsmiddel for fremstilling av en vanndig filmdannende sammensetning
WO2006013369A3 (en) Compositions forming non-lamellar dispersions
WO2003032953A1 (en) Granules containing acid-unstable chemical in large amount
MEP36508A (en) Triazolopyrazine derivatives useful as anti-cancer agents
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
DK1663216T3 (da) Tacrolimus-holdige sammensætninger med modificeret frigivelse
WO2006002361A3 (en) 2-methylpropanamides and their use as pharmaceuticals
WO2006113631A3 (en) Bioenhanced compositions
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
WO2007043057A3 (en) Compositions for nasal delivery
ATE522204T1 (de) Beschichtete pellets
WO2007022023A3 (en) Film forming spreading agents
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
GB0401513D0 (en) Compositions
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
CA2388325A1 (en) Ciclesonide-containing aqueous pharmaceutical composition
WO2006041538A3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
MXPA05011607A (es) Formulacion para producir un medicamento antimicrobinao potente contra organismos normalmente considerados resistentes al medicamento.
DE50310932D1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
ATE465715T1 (de) Orales abgabesystem mit einem biliquid foam
ITTO20040682A1 (it) Formulazione per somministrazione orale avente un effetto salutistico sull'apparato cardiovascolare
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors